Pain Pumps Market Size, Share and Global Trend, By Application (Spinal Cord Injury,Cancer Pain,Cerebral Palsy,Stroke,Brain Injury, Others), By Product Type(Reusable Pumps, Disposable Pumps), By End User(Pain Clinics,Hospitals, Ambulatory Surgery Centres (ASCs),Homecare Settings, Others)and Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
Pain pumps are electrochemical devices which are used to deliver the monitored amount of drugs into the patient body to manage pain. These pumps are operated by technological experts who are responsible for designing duration and dose of medicine to be delivered into the patient body by using the software. Pain pumps offer precision in terms of duration and quantity of dose administered, over manual infusion, and play a major role in restoring the health of patient after surgery. These medications are key for the normal recovery and the normal functioning for the patients suffering from chronic and acute pain due to medical conditions. These trends, coupled with technological advancements, are anticipated to contribute to the positive growth of the global pain pumps market.
Rise in need of minimally invasive techniques, reducing the demand for oral pain medication, increased patient preference due to effective pain relief and improved care are significant drivers for the growth of the global pain pumps market. These combined with, improved quality of life due to participation in day to day activities are significant drivers for the growth of global pain pumps market. According to the National Spinal Cord Injury Statistical Centre, in the U.S., 17,500 incidences of spinal cord injury were reported in 2017.
To gain extensive insights into the market, Request for Customization
Certain factors such as lack of efficiency in drug delivery due to air blockage, shortage of trained professional experts and high costs are some of the restraining factors for the growth of the global pain pumps market during the forecast period.
Key Players Covered
Some of the major companies that are present in the global pain pumps market are Medtronic, FLOWONIX MEDICAL INC., Johnson & Johnson Services, Inc., Teleflex Incorporated., Medallion Therapeutics, Inc., tricumed Medizintechnik GmbH, and others.
Segmentation
Segmentation | Details |
By Application | · Spinal Cord Injury · Cancer Pain · Cerebral Palsy · Stroke · Brain Injury · Others |
By Product Type | · Reusable Pumps · Disposable Pumps |
By End User | · Pain Clinics · Hospitals · Ambulatory Surgery Centres (ASCs) · Homecare Settings · Others |
By Geography | · North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
Among the segmentation, cancer pain in the application segment is projected to hold a considerable share of the global pain pumps market due to higher adoption of pain pumps for the relieving of cancer pain in developed as well as developing countries.
Key Insights
PESTEL analysis
Pricing analysis of key players in major countries/regions
Recent advancements in the global pain pump market
Recent industry developments such as partnerships, mergers, and acquisitions
Demand analysis
Market strategy of key players
Regional Analysis
North America is anticipated to dominate the global pain pumps market owing to the increasing prevalence of chronic pain, growing incidence of spinal cord injuries, improved nurse education and training, advanced healthcare facilities and emphasis on minimally invasive techniques for pain management. The Asia Pacific and Middle East & Africa hold huge potential for global pain pumps market owing to growth in demand of better pain management devices, rise in geriatric population, and the increasing availability of pain pumps in the market are some of the major factors driving the adoption and consumption of pain pumps in the region.
Key Industry Developments
- In March 2019, Piramal Critical Care announced the launch of their intrathecal pump product offering of MITIGO (Morphine Sulfate Injection, USP – Preservative-free), in the U.S. market.
- In January 2019, Medtronic launched the study of patients suffering from intractable non-malignant primary back pain with or without leg pain in its product offering of SynchroMed intrathecal drug delivery system, in order to reduce dependence on the consumption of oral opioids
- In October 2018, Medtronic announced the launch of Control Workflow in the U.S., which uses an evidence based approach for usage with their product offering of SynchroMed II intrathecal drug delivery system also known as Medtronic pain pump
- Ongoing
- 2023
- 2019-2022
-
Get in Touch with Us
-
US +1 833 909 2966 ( Toll Free )
-
